Please Note
We brought you to this page based on your search query. If this isn't what you are looking for, you can continue to Search Results for ""
The maximum number of items you can export is 3,000. Please reduce your list by using the filtering tool to the left.
Close
Chystáte se opustit lokální stránky Czech Proto budete přesměrování na celosvětové stránky, které jsou dostupné?
Nezobrazujte znovu tuto zprávu
Ano
Ne

Vyhledávali jste podle

Hledali jste

Relevantní informace

Důležité kontakty

Připravované akce

Příbuzné produkty

Farmaceutika, všeobecně a speciální - Luxembourg

Nejdůležitější body

Výzkum a studie
Organizace
Upřesněte, prosím, svou studii podle segmentu trhu, aby bylo možno získat odpovídající ratingy a monitorované údaje.
  DatumTyp dokumentu Název Emitent/entita
02 Apr 2024 Rating Action Moody's upgrades Galderma's rating to Ba2; outlook stable Sunshine Luxembourg VII SARL
18 Mar 2024 Rating Action Moody's places Galderma's ratings on review for upgrade Sunshine Luxembourg VII SARL
08 Mar 2024 Issuer Comment Sunshine Luxembourg VII SARL: Galderma's announced intention to float is credit positive Sunshine Luxembourg VII SARL
16 Feb 2024 Rating Action Moody's upgrades Novartis' rating to Aa3 and changes its outlook to stable Novartis AG
Novartis Capita...
Novartis Financ...
Novartis Financ...
Novartis Securi...
25 Jan 2024 Rating Action Moody's upgrades Jazz Pharma's CFR to Ba2; stable outlook Jazz Financing ...
Jazz Financing ...
Jazz Pharmaceut...
Jazz Pharmaceut...
Jazz Securities...
12 Jan 2024 Rating Action Moody's withdraws Covis's ratings for business reasons Covis Finco S.a...
Covis Parent SC...
09 Jan 2024 Announcement Moody's appends limited default (/LD) to Covis' Ca-PD PDR following payment default Covis Parent SCA
22 Dec 2023 Rating Action Moody's downgrades Covis to Caa3; outlook negative Covis Finco S.a...
Covis Parent SC...
19 Dec 2023 Credit Opinion Rossini S.a r.l: Update to credit analysis Rossini S.a r.l
14 Dec 2023 Announcement of Periodic Review Moody's announces completion of a periodic review for a group of Pharmaceutical issuers ADVANZ PHARMA H...
AI Sirona (Luxe...
Almirall, S.A.
AstraZeneca Fin...
AstraZeneca PLC
Cerebro HoldCo ...
Cheplapharm Arz...
Cidron Aida Fin...
Covis Finco S.a...
Covis Parent SC...
...
Complete Your Profile
Please complete your profile before submitting your comments.
We're Sorry